🇺🇸 FDA
Pipeline program

VGX-3100

HPV-301

Phase 3 mab completed

Quick answer

VGX-3100 for Cervical Dysplasia is a Phase 3 program (mab) at INOVIO PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
INOVIO PHARMACEUTICALS, INC.
Indication
Cervical Dysplasia
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials